10 things to know about eCTD 4.0: Embracing the future regulatory submissions Blog 10 个关于 eCTD 4.0 的须知事项:迎接未来的监管提交 In this blog post, we explore the top 10 things you need to know about…Certara2023 年 10 月 17 日
Maximizing reusability for drug submissions to different health authorities Blog Maximizing reusability for drug submissions to different health authorities Many drug developers have products that they want to submit for marketing approval in several…Certara2023 年 9 月 21 日
3 takeaways from the FDA oligo guidance you need to know Blog 3 takeaways from the FDA oligo guidance you need to know In June 2022, the FDA published their first oligonucleotide clinical pharmacology specific guidance . This…Certara2022 年 9 月 23 日
Choosing an eCTD submissions vendor: Your complete checklist Blog Choosing an eCTD submissions vendor: Your complete checklist 2025 年 9 月 3 日 Selecting the right electronic submission vendor for regulatory submissions to health authorities…Certara2022 年 1 月 28 日
Why your regulatory writers need eCTD authoring templates Blog Why your regulatory writers need eCTD authoring templates If you’ve heard about eCTD authoring template suites before, but you’re not sure what they…Certara2021 年 5 月 14 日